These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 11175346

  • 1. Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest.
    Simoneau M, LaRue H, Aboulkassim TO, Meyer F, Moore L, Fradet Y.
    Oncogene; 2000 Dec 14; 19(54):6317-23. PubMed ID: 11175346
    [Abstract] [Full Text] [Related]

  • 2. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.
    Bartoletti R, Cai T, Nesi G, Roberta Girardi L, Baroni G, Dal Canto M.
    J Surg Res; 2007 Dec 14; 143(2):422-7. PubMed ID: 17612565
    [Abstract] [Full Text] [Related]

  • 3. Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31.
    Simoneau M, Aboulkassim TO, LaRue H, Rousseau F, Fradet Y.
    Oncogene; 1999 Jan 07; 18(1):157-63. PubMed ID: 9926930
    [Abstract] [Full Text] [Related]

  • 4. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR, Spruck CH, Gonzalez-Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, Dean M, Steven K, Horn T, Jones PA.
    Cancer Res; 1996 Nov 01; 56(21):5039-43. PubMed ID: 8895761
    [Abstract] [Full Text] [Related]

  • 5. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L, Bottarelli L, Bader G, Iusco D, Pizzi S, Costi R, D'Adda T, Bertolani M, Roncoroni L, Bordi C.
    Dis Colon Rectum; 2004 Sep 01; 47(9):1467-82. PubMed ID: 15486743
    [Abstract] [Full Text] [Related]

  • 6. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.
    Edwards J, Duncan P, Going JJ, Grigor KM, Watters AD, Bartlett JM.
    Br J Cancer; 2001 Dec 14; 85(12):1894-9. PubMed ID: 11747332
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of loss of heterozygosity at chromosome 9p in non-muscle-invasive bladder cancer.
    Ploussard G, Dubosq F, Soliman H, Verine J, Desgrandchamps F, De Thé H, Mongiat-Artus P.
    Urology; 2010 Aug 14; 76(2):513.e13-8. PubMed ID: 20605198
    [Abstract] [Full Text] [Related]

  • 8. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
    Mihaila D, Jankowski M, Gutiérrez JA, Rosenblum ML, Newsham IF, Bögler O, Rempel SA, NABTT CNS Consortium.
    Clin Cancer Res; 2003 Oct 01; 9(12):4443-51. PubMed ID: 14555517
    [Abstract] [Full Text] [Related]

  • 9. The random development of LOH on chromosome 9q in superficial bladder cancers.
    van Tilborg AA, de Vries A, de Bont M, Groenfeld LE, Zwarthoff EC.
    J Pathol; 2002 Nov 01; 198(3):352-8. PubMed ID: 12375268
    [Abstract] [Full Text] [Related]

  • 10. Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder.
    Erbersdobler A, Friedrich MG, Schwaibold H, Henke RP, Huland H.
    Oncol Res; 1998 Nov 01; 10(8):415-20. PubMed ID: 10100758
    [Abstract] [Full Text] [Related]

  • 11. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
    Gicquel C, Bertagna X, Gaston V, Coste J, Louvel A, Baudin E, Bertherat J, Chapuis Y, Duclos JM, Schlumberger M, Plouin PF, Luton JP, Le Bouc Y.
    Cancer Res; 2001 Sep 15; 61(18):6762-7. PubMed ID: 11559548
    [Abstract] [Full Text] [Related]

  • 12. Prognostic role of loss of heterozygosity on chromosome 18 in patients with low-risk nonmuscle-invasive bladder cancer: results from a prospective study.
    Cai T, Nesi G, Dal Canto M, Mondaini N, Piazzini M, Bartoletti R.
    J Surg Res; 2010 Jun 01; 161(1):89-94. PubMed ID: 19500801
    [Abstract] [Full Text] [Related]

  • 13. Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.
    Edwards J, Duncan P, Going JJ, Watters AD, Grigor KM, Bartlett JM.
    J Pathol; 2002 Apr 01; 196(4):380-5. PubMed ID: 11920732
    [Abstract] [Full Text] [Related]

  • 14. Mapping of genetic deletions on chromosome 3 in colorectal cancer: loss of 3p25-pter is associated with distant metastasis and poor survival.
    Tsai MH, Fang WH, Lin SH, Tzeng ST, Huang CS, Yen SJ, Chou SJ, Yang YC.
    Ann Surg Oncol; 2011 Sep 01; 18(9):2662-70. PubMed ID: 21347784
    [Abstract] [Full Text] [Related]

  • 15. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
    Divrik RT, Sahin A, Altok M, Unlü N, Zorlu F.
    J Urol; 2007 Sep 01; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
    [Abstract] [Full Text] [Related]

  • 16. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S, Mohren K, Knuechel R, Wild PJ, Burger M, Wieland WF, Hartmann A, Stoehr R.
    Hum Pathol; 2006 Feb 01; 37(2):143-51. PubMed ID: 16426913
    [Abstract] [Full Text] [Related]

  • 17. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T, Nesi G, Boddi V, Mazzoli S, Dal Canto M, Bartoletti R.
    Oncol Rep; 2006 Aug 01; 16(2):329-34. PubMed ID: 16820911
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB, Zeng FH, Sun ZQ.
    Chin Med J (Engl); 2006 Nov 05; 119(21):1821-8. PubMed ID: 17097038
    [Abstract] [Full Text] [Related]

  • 19. [The diagnostic value of microsatellite LOH analysis and the prognostic relevance of angiogenic gene expression in urinary bladder cancer].
    Szarvas T.
    Magy Onkol; 2009 Dec 05; 53(4):385-9. PubMed ID: 20071311
    [Abstract] [Full Text] [Related]

  • 20. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.
    Stoehr R, Zietz S, Burger M, Filbeck T, Denzinger S, Obermann EC, Hammerschmied C, Wieland WF, Knuechel R, Hartmann A.
    Eur Urol; 2005 Jan 05; 47(1):58-63. PubMed ID: 15582250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.